Cartilage
-
Biologics
Allosource’s Cartilage Allograft Expertise to be Featured at the International Cartilage Regeneration & Joint Preservation Society Annual Meeting
CENTENNIAL, Colo., April 5, 2022 /PRNewswire/ — AlloSource®, one of the largest allograft providers creating innovative cellular and tissue allografts to help surgeons…
Read More » -
Regulatory
FDA approves CartiHeal’s Implant for the Treatment of Cartilage and Osteochondral Defects
Approval is based on results of a multicenter, randomized, open-labeled and controlled IDE clinical study that demonstrated the superiority of…
Read More » -
Extremities
CartiHeal Announces Pivotal Study Results Demonstrate Agili-C™ Superiority to Microfracture and Debridement for the Treatment of Cartilage and Osteochondral Defects
According to a Two-Year Randomized and Controlled Multinational IDE Study KFAR SABA, Israel, Aug. 3, 2021 /PRNewswire/ — CartiHeal Ltd, developer of Agili-C™,…
Read More » -
Sports Medicine
RSIP Vision Announces New Tool for Sports Medicine Applications, Enabling Automated Assessment of Cartilage Damage
This new algorithmic software provides automated measurement of articular cartilage in MRI scans, thereby improving evaluation of the integrity and…
Read More » -
Biologics
Science Behind AlloSource’s Cryopreserved Cartilage Published In Journal Of Orthopaedic Surgery And Research
CENTENNIAL, Colo., Dec. 8, 2020 /PRNewswire/ — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products…
Read More » -
Sports Medicine
AlloSource Announces First Patients Complete 12-Month Milestone In ProChondrix CR Clinical Study For Cartilage Defects In The Knee
CENTENNIAL, Colo., Nov. 17, 2020 /PRNewswire/ –AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products,…
Read More » -
Biologics
New Approach to Treating Osteoarthritis Advances
NEW YORK, Aug. 10, 2020 /PRNewswire/ — Injections of a natural “energy” molecule prompted regrowth of almost half of the cartilage lost…
Read More » -
Biologics
Novel Tissue Preservation Method Improves Outcomes in Cartilage Transplant Procedures in the Knee
COLUMBIA, Mo. (July 8, 2020) ― A University of Missouri study on clinical outcomes after biologic knee restoration surgery found…
Read More » -
Biologics
Nanostructured rubber-like material with optimal properties could replace human tissue
March 16, 2020 / Chalmers University of Technology Researchers from Chalmers University of Technology, Sweden, have created a new, rubber-like…
Read More » -
Extremities
Paragon 28® Launches Unique Option for Revising a Failed Synthetic Cartilage Implant (SCI)
ENGLEWOOD, Colo., Dec. 13, 2019 /PRNewswire/ — Since its inception, Paragon 28® has obsessed over every aspect of foot and ankle surgery.…
Read More » -
Extremities
CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedure in Maryland
Dr. Scopp performs first Agili-C™ cartilage repair implantation procedure in Maryland KFAR SABA, Israel, Oct. 15, 2019 /PRNewswire/ — CartiHeal, developer of Agili-C™,…
Read More » -
Biologics
Research Shows ProChondrix® CR Maintains Consistent, High Cell Viability For Two Years
CENTENNIAL, Colo., Oct. 7, 2019 /PRNewswire/ — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and…
Read More » -
Biologics
Educate Your Patients…or They Will Take Medical Advice From Their Hairdresser
By Elizabeth Hofheinz, M.P.H., M.Ed., August 30, 2019 “When it comes to stem cells and PRP, we wage a battle…
Read More » -
Biologics
AlloSource Celebrates 25 Years Of Doing More With Life
CENTENNIAL, Colo., Aug. 9, 2019 /PRNewswire/ — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, will…
Read More » -
Hospitals
SpinalCyte, LLC Announces New U.S. Patent
August 28, 2018 HOUSTON–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc using Human…
Read More »